Page last updated: 2024-08-17

2,6-xylidine and Bladder Cancer

2,6-xylidine has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Conti, DV; Cortessis, VK; Day, BW; Gago-Dominguez, M; Gao, YT; Hu, B; Pike, MC; Stern, MC; Tao, L; Van Den Berg, D; Wang, R; Xiang, YB; Yu, MC; Yuan, JM	1

Other Studies

1 other study(ies) available for 2,6-xylidine and Bladder Cancer

Article	Year
Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2013, Volume: 22, Issue:5 Topics: Aged; Aniline Compounds; Biomarkers, Tumor; Case-Control Studies; Female; Hemoglobins; Humans; Male; Middle Aged; Risk Factors; Smoking; Urinary Bladder Neoplasms	2013

Article

Year

Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2013, Volume: 22, Issue:5

Topics: Aged; Aniline Compounds; Biomarkers, Tumor; Case-Control Studies; Female; Hemoglobins; Humans; Male; Middle Aged; Risk Factors; Smoking; Urinary Bladder Neoplasms

2013